{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T08:02:45Z","timestamp":1697443365868},"reference-count":46,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.ejphar.2004.07.093","type":"journal-article","created":{"date-parts":[[2004,8,31]],"date-time":"2004-08-31T13:27:23Z","timestamp":1093958843000},"page":"163-169","source":"Crossref","is-referenced-by-count":11,"title":["Intravenous atenolol and esmolol maintain the protective effect of ischemic preconditioning in vivo"],"prefix":"10.1016","volume":"499","author":[{"given":"Efstathios K.","family":"Iliodromitis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Androniki","family":"Tasouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioanna","family":"Andreadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Bofilis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Zoga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Cokkinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios Th.","family":"Kremastinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2004.07.093_bib1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.RES.73.4.656","article-title":"Preconditioning against myocardial dysfunction after ischemia and reperfusion by a \u03b11-adrenergic mechanism","volume":"73","author":"Banerjee","year":"1993","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2004.07.093_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/phrs.1996.0114","article-title":"Hemodynamic changes do not mediate the cardioprotection induced by the A1, adenosine receptor agonist CCPA in the rabbit","volume":"35","author":"Casati","year":"1997","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2004.07.093_bib3","first-page":"H902","article-title":"Ischemic preconditioning in human myocardium: protein kinase C mediates a permissive role for alpha adrenoreceptors","volume":"273","author":"Cleveland","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2004.07.093_bib46","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/01.RES.74.5.998","article-title":"Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning","volume":"74","author":"Cohen","year":"1994","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2004.07.093_bib4","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1161\/01.CIR.94.7.1713","article-title":"Phospholipase D plays a role in ischemic preconditioning in rabbit heart","volume":"94","author":"Cohen","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2004.07.093_bib5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/01.STR.32.3.767","article-title":"Cardioprotection in pigs by exogenous norepineprhine but not cerebral ischemia-induced release of endogenous norepinephrine","volume":"32","author":"De Zeeuw","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2004.07.093_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0014-2999(98)00326-4","article-title":"Comparison of metorprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model","volume":"351","author":"Feuerstein","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.07.093_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0014-2999(00)00641-5","article-title":"Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model","volume":"406","author":"Gao","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.07.093_bib7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0008-6363(02)00441-8","article-title":"Gap junction-mediated intercellular communication in ischemic preconditioning","volume":"55","author":"Garcia-Dorado","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2004.07.093_bib9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/01.RES.77.3.611","article-title":"Role of bradykinin in protection of ischemic preconditioning in rabbit hearts","volume":"77","author":"Goto","year":"1995","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2004.07.093_bib10","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1006\/jmcc.1998.0654","article-title":"Intramyocardial infusion of FGF-1 mimics ischemic preconditioning in pig myocardium","volume":"30","author":"Htun","year":"1998","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2004.07.093_bib11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1161\/01.RES.78.3.492","article-title":"Protein kinase C activates ATP-sensitive K+ current in human and rabbit ventricular myocytes","volume":"78","author":"Hu","year":"1996","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2004.07.093_bib12","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1006\/jmcc.1996.0328","article-title":"Multiple cycles of preconditioning cause loss of protection in open-chest rabbits","volume":"29","author":"Iliodromitis","year":"1997","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2004.07.093_bib13","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1006\/jmcc.1998.0780","article-title":"The PKC activator PMA preconditions rabbit heart in the presence of adenosine receptor blockade: is 5\u2032-nucleotidase important?","volume":"30","author":"Iliodromitis","year":"1998","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2004.07.093_bib14","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/sj.bjp.0705149","article-title":"Oral nicorandil recaptures the waned protection from preconditioning in vivo","volume":"138","author":"Iliodromitis","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.07.093_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM198401053100103","article-title":"Reduction of infarct size with the early use of timolol in acute myocardial infarction","volume":"310","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2004.07.093_bib16","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1161\/01.CIR.97.18.1848","article-title":"Medical and cellular implications of stunning, hibernation, and preconditioning. An NHLBI Workshop","volume":"97","author":"Kloner","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2004.07.093_bib47","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1006\/jmcc.1993.1156","article-title":"\"Dose\"-dependency and temporal characteristics of protection by ischemic preconditioning against ischemia-induced arrhythmias in rat hearts","volume":"25","author":"Lawson","year":"1993","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2004.07.093_bib17","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1161\/01.CIR.87.5.1642","article-title":"The cardioprotective effects of ischemic \u201cpreconditioning\u201d are not mediated by adenosine receptors in rat hearts","volume":"87","author":"Li","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2004.07.093_bib18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0008-6363(01)00321-2","article-title":"Role of adenosine in ischemic preconditioning in rats depends critically on the duration of the stimulus and involves both A(1) and A(3) receptors","volume":"51","author":"Liem","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2004.07.093_bib19","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0735-1097(97)00347-1","article-title":"Ischemic preconditioning in unstable coronary syndromes: evidence for time dependence","volume":"30","author":"Lim","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2004.07.093_bib20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1161\/01.CIR.84.1.350","article-title":"Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart","volume":"84","author":"Liu","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2004.07.093_bib21","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/01.CIR.100.9.958","article-title":"Ischemic preconditioning and the \u03b2-adrenergic signal transduction pathway","volume":"100","author":"Lochner","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2004.07.093_bib22","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00005344-199704000-00002","article-title":"\u03b2-Adrenoreceptor stimulation-mediated preconditioning-like cardioprotection in perfused rat hearts","volume":"29","author":"Nasa","year":"1997","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.07.093_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1161\/01.CIR.91.2.291","article-title":"Prodroma angina limits infarct size; a role for ischemic preconditioning","volume":"91","author":"Ottani","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2004.07.093_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/00325481.1994.11945876","article-title":"Unstable angina: pharmaceutical versus invasive therapy","volume":"96","author":"Prissant","year":"1994","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.ejphar.2004.07.093_bib25","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.CIR.96.3.984","article-title":"Ischemic preconditioning. Differences in protection and susceptibility to blockade with single-cycle versus multicycle transient ischemia","volume":"96","author":"Sandhu","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2004.07.093_bib26","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1096\/fj.99-0671com","article-title":"The role of differential activation of p-38-mitogen-activated protein kinase in preconditioned ventricular myocytes","volume":"14","author":"Saurin","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2004.07.093_bib27","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1006\/jmcc.1997.0454","article-title":"Ischemic preconditioning and morhine-induced cardioprotection through bradykinin B2 receptor activation in human heart","volume":"29","author":"Schultz","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2004.07.093_bib28","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/01.CIR.98.10.1022","article-title":"Ischemic preconditioning in pigs: a graded phenomenon: its relation to adenosine and bradykinin","volume":"98","author":"Schultz","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2004.07.093_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0008-6363(01)00384-4","article-title":"Signal transduction of ischemic preconditioning","volume":"52","author":"Schulz","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2004.07.093_bib30","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1161\/01.RES.77.5.1030","article-title":"Does ischemic preconditioning in the human heart involve protein kinase C and the ATP-dependent K+ channel?","volume":"77","author":"Speechly-Dick","year":"1995","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2004.07.093_bib31","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.RES.70.4.670","article-title":"Effect of \u03b1-adrenergic stimulation on activation of protein kinase C and phosphorylation of proteins in intact rabbit hearts","volume":"70","author":"Talosi","year":"1992","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2004.07.093_bib32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/oxfordjournals.eurheartj.a061845","article-title":"Metoprolol in acute myocardial infarction (MIAMI). A randomized placebo-controlled international trial","volume":"6","year":"1985","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2004.07.093_bib33","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/01.RES.73.4.649","article-title":"Catecholamines can induce adenosine receptor-mediated protected myocardium but do no participate in ischemic preconditioning in the rabbit","volume":"73","author":"Thornton","year":"1993","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2004.07.093_bib35","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1161\/01.CIR.96.7.2171","article-title":"Pentolamine prevents adaptation to ischemia during coronary angioplasty. Role of \u03b1-adrenergic receptors in ischemic preconditioning","volume":"96","author":"Tomai","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2004.07.093_bib34","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/01.CIR.88.5.2351","article-title":"Ischemic preconditioning fails to limit infarct size in reserpinized rabbit myocardium. Implication of norepinephrine release in the preconditioning effect","volume":"88","author":"Toombs","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2004.07.093_bib36","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/01.RES.80.5.743","article-title":"Oxygen radicals can induce preconditioning in rabbit hearts","volume":"80","author":"Tritto","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2004.07.093_bib37","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/cvr\/26.5.456","article-title":"Role of adenosine receptor activation in myocardial infarct size limitation by ischemic preconditioning","volume":"26","author":"Tsuchida","year":"1992","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2004.07.093_bib38","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/01.RES.75.3.576","article-title":"\u03b1-Adrenergic agonists precondition rabbit heart ischemic myocardium independent of adenosine by direct activation of protein kinase C","volume":"75","author":"Tsuchida","year":"1994","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.ejphar.2004.07.093_bib39","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/0008-6363(95)00074-7","article-title":"Effect of catecholamine depletion on myocardial infarct size in dogs: role of catecholamines in ischemic preconditioning","volume":"30","author":"Vander Heide","year":"1995","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2004.07.093_bib40","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0022-2828(05)82397-1","article-title":"Preconditioning in isolated superfused human muscle","volume":"27","author":"Walker","year":"1995","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2004.07.093_bib41","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1006\/jmcc.1996.0054","article-title":"Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit hearts","volume":"28","author":"Wang","year":"1996","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2004.07.093_bib43","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/00005344-199812000-00013","article-title":"Pharmacologic preconditioning induced by b-adrenegic stimulation is mediated by activation of protein kinase C","volume":"32","author":"Yabe","year":"1998","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.07.093_bib44","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0140-6736(93)91819-8","article-title":"Preconditioning the human myocardium","volume":"342","author":"Yellon","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2004.07.093_bib45","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1001\/jama.260.14.2088","article-title":"Overview of results of randomized clinical trials in heart disease. Treatments following myocardial infarction","volume":"260","author":"Yusuf","year":"1988","journal-title":"JAMA"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904008271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904008271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T11:20:07Z","timestamp":1549279207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299904008271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":46,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0014299904008271"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2004.07.093","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}